Abstract

BackgroundMouse mammary tumour virus (MMTV) is a betaretrovirus that infects rodent cells and uses mouse tranferrin receptor 1 (TfR1) for cell entry. Several MMTV strains have been shown to productively infect, in addition to murine cells, various heterologous cell lines including those of human origin, albeit less efficiently than murine cells. Furthermore, there have been reports that the continued passage of MMTV in heterologous cell lines gives rise to novel variants that are able to infect naive non-murine cells with higher efficiency than the parental virus.ResultsWe show that MMTV(C3H), like other MMTV strains, that had undergone a number of replication cycles in non-murine cells displayed an increased replication kinetic, as compared to parental virus, when applied on naive human cells. Sequence analysis of several replication kinetic variants and the parental virus, together with calculation of the ratio of non-synonymous to synonymous mutations at individual codons, revealed that several regions within the viral genome were under strong positive selection pressure during viral replication in human cells. The mutation responsible, at least in part, for the phenotypic change was subsequently mapped to the segment of env encoding the receptor binding site (F40HGFR44). Introduction of the identified mutation, leading to single amino acid substitution (G42E), into egfp-containing recombinant MMTV virions enhanced their ability to bind to and infect human cells. Interestingly, neither the replication kinetic mutant nor the parental virus required human TfR1 for infection. Knock-out of TFR1 gene from the human genome did not decrease the susceptibility of Hs578T cells to virus infection. Furthermore, the expression of human TfR1, in contrast to mouse TfR1, did not enhance the susceptibility of MMTV-resistant Chinese hamster ovary cells. Thus, human TfR1 is dispensable for infection and another cell surface molecule mediates the MMTV entry into human cells.ConclusionTaken together, our data explain the mechanism enabling MMTV to form ‘host-range variants’ in non-murine cells that has been known for a long time, the basis of which remained obscure. Our findings may expand our understanding of how viruses gain capability to cross species-specific barriers to infect new hosts.Electronic supplementary materialThe online version of this article (doi:10.1186/s12977-015-0168-2) contains supplementary material, which is available to authorized users.

Highlights

  • Mouse mammary tumour virus (MMTV) is a betaretrovirus that infects rodent cells and uses mouse tranferrin receptor 1 (TfR1) for cell entry

  • MMTV(C3H) particles released by the persistently infected human cells exhibit an accelerated cell-to-cell spread phenotype in human cells Previously, we have shown that wild-type MMTV(C3H) and a recombinant expressing the green fluorescent reporter protein (EGFP) containing virus carrying MMTV(C3H) Env could infect cultured human cells via a specific interaction of the viral envelope with the cell surface receptor [31]

  • The infectivity of MMTV(C3H)hp1 was blocked by neutralizing antiMMTV antibodies, demonstrating that virus particles released by the persistently infected human cells are antigenically related to the virus produced from murine cells [31]

Read more

Summary

Introduction

Mouse mammary tumour virus (MMTV) is a betaretrovirus that infects rodent cells and uses mouse tranferrin receptor 1 (TfR1) for cell entry. Several MMTV strains have been shown to productively infect, in addition to murine cells, various heterologous cell lines including those of human origin, albeit less efficiently than murine cells. Cross-species transmission of viruses is well documented. Understanding how viruses infect and spread in new hosts is central to understanding the pathogenesis of infection and emergence of disease. The virus cannot use hTfR1 for cell entry, several MMTV strains have been shown to productively infect, in addition to murine cells, various heterologous cell lines including those of human origin, albeit less efficiently than murine cells [7,8,9,10,11]. It has been reported that MMTV sequences have been detected in human breast cancer and primary biliary cirrhosis specimens [12,13,14,15,16,17], as well as in canine and feline neoplastic and normal mammary tissue [11]

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.